Podcast 94: What does a new meta-analysis tell us about statins and primary prevention?

A meta-analysis of 11 studies encompassing more than 60,000 subjects finds that statins don’t lower all-cause mortality in people without cardiovascular disease. One editorialist calls the study, just published in the Archives of Internal Medicine, “the cleanest and most complete meta-analysis of pharmacological lipid lowering for primary prevention.” One of the study’s principal authors, Kausik K. Ray, talked with us from London. I think you’ll find that listening in is worth your time. Interview-related links: • Physician’s First Watch coverage of the Archives‘s statin papers (http://firstwatch.jwatch.org/cgi/cont...) • Ray et al.‘s meta-analysis (http://archinte.ama-assn.org/cgi/cont...) News-related links: • Starting dialysis early doesn’t improve mortality (http://firstwatch.jwatch.org/cgi/cont...) • Digoxin’s dangers in dialysis (http://firstwatch.jwatch.org/cgi/cont...) • Rosiglitazone’s bad week (http://firstwatch.jwatch.org/cgi/cont...) • Tight glucose control in diabetes brings some benefits, but at the cost of “imprudent” risks (http://firstwatch.jwatch.org/cgi/cont...) • PSA testing for prostate cancer lowers mortality, but mostly in low-screening regions (http://firstwatch.jwatch.org/cgi/cont...) (https://www.addtoany.com/add_to/faceb...) (https://www.addtoany.com/add_to/twitt...) (https://www.addtoany.com/add_to/linke...) (https://www.addtoany.com/add_to/email...) (https://www.addtoany.com/share#url=ht...) The post Podcast 94: What does a new meta-analysis tell us about statins and primary prevention? (https://podcasts.jwatch.org/index.php...) first appeared on Clinical Conversations (https://podcasts.jwatch.org) .